Olodaterol Gets Approval from US FDA to Treat COPD
The US FDA have provided marketing approval for the daily once bronchodilator inhalation spray olodaterol (Striverdi Respimat) for the long-term
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine